CODEXIS INITIATES DIRECT SALES OF GENERIC PHARMACEUTICAL INTERMEDIATES

Codexis, Inc., a privately held biotechnology company, announced the company has expanded into direct sales of pharmaceutical intermediates with receipt of the first commercial orders from leading generics manufacturers for ATS-8, the key chemical intermediate in atorvastatin. Atorvastatin is the active ingredient in the world's largest-selling drug for lowering cholesterol. The announcement was made in conjunction with the 2006 CPHI (Convention of Pharmaceutical Ingredients and Intermediates) annual conference in Paris. PR Newswire (http://sev.prnewswire.com/medical-pharmaceuticals/20061003/SFTU00503102006-1.html) (http://allafrica.com/stories/200610010095.html)